M05.29, Rheumatoid vasculitis with rheumatoid arthritis of multiple sites

CGS-J15-L39427, MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis

J15

CGS-J15-L34399, Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)

J15

CGS-J18-L34399, Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)

J18

CGS-J18-L39427, MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis

J18

A55639, Billing and Coding: Chemotherapy Agents for Non-Oncologic Conditions

J5

WPS-J5-L39481, MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis

J5

A59536, Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis

J5

WPS-J5-L37205, Chemotherapy Drugs and their Adjuncts

J5

A59434, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

J5

A56795, Billing and Coding: Erythropoiesis Stimulating Agents (ESAs)

J5

WPS-J5-L34633, Erythropoiesis Stimulating Agents (ESAs)

J5

A52850, Billing and Coding: Cardiac Catheterization and Coronary Angiography

J6

A59101, Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars

J6

NGS-J6-L39297, Off-label Use of Rituximab and Rituximab Biosimilars

J6

A52423, Billing and Coding: Infliximab and biosimilars

J6

NGS-J6-L33394, Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

J6

NGS-J6-L33557, Cardiac Catheterization and Coronary Angiography

J6

A58893, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

J6

WPS-J8-L39481, MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis

J8

WPS-J8-L37205, Chemotherapy Drugs and their Adjuncts

J8